Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer

NCT01123473 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

29

Enrollment

NETWORK

Sponsor class

Stopped company withdrew interest

Conditions

Adenocarcinoma of the Gastroesophageal Junction
Gastric Cancer

Interventions

DRUG: capecitabine
DRUG: cisplatin
DRUG: epirubicin hydrochloride
DRUG: fluorouracil
DRUG: lapatinib ditosylate

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC